SHFA
GILD icon

SS&H Financial Advisors’s Gilead Sciences GILD Stock Holding History

SS&H Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,881
Closed -$885K – 123
2022
Q1 		$885K Buy
+14,881
New +$951K 0.35% 71

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SS&H Financial Advisors's GILD Position: Q2 2022 in Review

SS&H Financial Advisors sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 14,881 shares — an estimated $885K sold.

SS&H Financial Advisors first reported a position in GILD in Q1 2022 and held it in 1 quarter. The position peaked at $885K in Q1 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • SS&H Financial Advisors reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • SS&H Financial Advisors sold 14,881 Gilead Sciences shares in Q2 2022, an estimated $885K.
  • SS&H Financial Advisors first reported a position in Gilead Sciences in Q1 2022 and held it in 1 quarter.
  • SS&H Financial Advisors's Gilead Sciences position peaked at $885K in Q1 2022.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on SS&H Financial Advisors's 13F filing for Q2 2022, filed 14 Jul 2022.